National Institutes of Health: all 11,571 studies

Page 111 of 116. Open to participants first (945), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell CountsCompletedNCT00000908
• A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive PatientsCompletedNCT00000907
• Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected PatientsCompletedNCT00000906Phase 1
• A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV TherapyCompletedNCT00000905
• Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative AdultsCompletedNCT00000904Phase 1
• Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment RegimenCompletedNCT00000903Phase 3
• A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior TreatmentCompletedNCT00000902Phase 1
• Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected ChildrenCompletedNCT00000901Phase 1
• The Effects of Illnesses on HIV Levels in the BodyCompletedNCT00000900
• A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive PatientsCompletedNCT00000899Phase 1
• The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and SaquinavirCompletedNCT00000898Not applicable
• A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and WomenCompletedNCT00000897Not applicable
• A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive PatientsCompletedNCT00000896Not applicable
• A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV InfectionCompletedNCT00000895Not applicable
• Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV RetinitisCompletedNCT00000894Phase 4
• Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive ChildrenCompletedNCT00000893Phase 1
• A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used IndinavirCompletedNCT00000892Not applicable
• Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315CompletedNCT00000891Phase 2
• A Study to Evaluate the Effect of Anti-HIV Therapy on Lean Tissue (Muscle) in HIV-Positive PatientsCompletedNCT00000890
• A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3CompletedNCT00000889Phase 2
• Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their BabiesCompletedNCT00000888Phase 1
• A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their InfantsCompletedNCT00000887Phase 1
• A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)CompletedNCT00000886Phase 1
• Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320CompletedNCT00000885Phase 2
• A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult VolunteersCompletedNCT00000884Phase 1
• Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV TherapyCompletedNCT00000883Not applicable
• Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced SubjectsCompletedNCT00000882Phase 2
• A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) DiseaseWithdrawnNCT00000881Phase 1
• A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV DiseaseCompletedNCT00000880Phase 2
• A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive MothersCompletedNCT00000879Phase 1
• A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their InfantsCompletedNCT00000878Phase 1
• Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative AdultsCompletedNCT00000877Phase 1
• Safety and Effectiveness of CD4-IgG2 in HIV-Positive ChildrenCompletedNCT00000876Phase 1
• Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 InfectionTerminatedNCT00000875Not applicable
• A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GARTCompletedNCT00000874
• A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected InfantsCompletedNCT00000873Not applicable
• Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV InfectionCompletedNCT00000872Phase 2
• A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult VolunteersCompletedNCT00000871Phase 2
• A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART AloneCompletedNCT00000870Phase 2
• A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their BabiesCompletedNCT00000869Phase 3
• A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative VolunteersCompletedNCT00000868Phase 1
• A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)CompletedNCT00000867Phase 2
• A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.CompletedNCT00000866Not applicable
• The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and ChildrenCompletedNCT00000865Phase 1
• A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected WomenCompletedNCT00000864Phase 1
• A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected PatientsCompletedNCT00000863Phase 2
• A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant WomenCompletedNCT00000862Phase 1
• The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected PatientsCompletedNCT00000861Not applicable
• The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected PatientsCompletedNCT00000860
• A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3CompletedNCT00000859Not applicable
• Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other InfectionsCompletedNCT00000858
• A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3CompletedNCT00000857Phase 1
• A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.WithdrawnNCT00000856Phase 1
• A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.CompletedNCT00000855Not applicable
• A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight LossCompletedNCT00000854Phase 1
• A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy AdultsCompletedNCT00000853Phase 1
• A Pilot Study of Allogeneic Lymphocyte Transfer in HIV InfectionCompletedNCT00000852Not applicable
• Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected ChildrenCompletedNCT00000851Phase 2
• The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV TherapyCompletedNCT00000850Phase 2
• A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected ChildrenCompletedNCT00000849Phase 1
• The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One YearCompletedNCT00000848Phase 2
• A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult VolunteersCompletedNCT00000847Phase 1
• A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.CompletedNCT00000846Phase 1
• A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human SubjectsCompletedNCT00000845Phase 1
• A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3CompletedNCT00000844Not applicable
• The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected ChildrenCompletedNCT00000843Phase 1
• A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory NeuropathyCompletedNCT00000842Phase 2
• A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More MonthsCompletedNCT00000841Phase 3
• A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNACompletedNCT00000840
• A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant WomenCompletedNCT00000839Phase 1
• Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or DidanosineCompletedNCT00000838Phase 2
• A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected ChildrenCompletedNCT00000837Phase 1
• A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)CompletedNCT00000836Phase 2
• A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Pseudovirion VaccineWithdrawnNCT00000835
• A Phase I Study of Methotrexate for HIV InfectionCompletedNCT00000834Phase 1
• A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.CompletedNCT00000833Phase 1
• A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult VolunteersCompletedNCT00000832Phase 1
• Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI MonotherapyCompletedNCT00000831Phase 2
• Intracellular Pharmacokinetics of Zidovudine Triphosphate in Maternal and Infant Cord Blood Mononuclear Cells.CompletedNCT00000830
• A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected InfantsCompletedNCT00000829Phase 1
• Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With ZidovudineCompletedNCT00000828
• A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected ChildrenCompletedNCT00000827Phase 1
• Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine MetabolitesCompletedNCT00000826Phase 1
• The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3CompletedNCT00000825Phase 2
• A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected PatientsTerminatedNCT00000824Not applicable
• A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 InfectionCompletedNCT00000823Phase 2
• A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T CellsCompletedNCT00000822Phase 1
• Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected PatientsCompletedNCT00000821Phase 1
• A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral TherapyCompletedNCT00000820Phase 2
• A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN)CompletedNCT00000819Phase 2
• Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3.CompletedNCT00000818Phase 1
• The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected PatientsCompletedNCT00000817Not applicable
• Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia ProphylaxisCompletedNCT00000816Phase 4
• A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials GroupCompletedNCT00000815Phase 2
• A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV DiseaseCompletedNCT00000814Phase 1
• A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN (ALVAC vCP125, HIV-1 gp160 MN) in HIV-1 Uninfected Adult VolunteersCompletedNCT00000813Phase 1
• A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 InfectionCompletedNCT00000812Phase 1
• A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive ChildrenCompletedNCT00000811Phase 2
• Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)CompletedNCT00000810Phase 1
• Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected WomenWithdrawnNCT00000809Phase 1

← National Institutes of Health overview and focus areas